Found 8 matching trials
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma PHASE2 The primary objective of the study is to evaluate the effect of multiple-do...
Show More Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma PHASE1 Evaluate the safety and tolerability of MEDI-563 in adults with asthma and ...
Show More Learn More & Join Trial
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations PHASE3 Phase 3 study to evaluate the efficacy and safety of a benralizumab in pati...
Show More Learn More & Join Trial
Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The current literature suggests that the mode of action of benralizumab is ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma PHASE2 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Learn More & Join Trial
A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab PHASE4 This is a multicentre, randomised, open-label, parallel-group, active-contr...
Show More Learn More & Join Trial
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype PHASE3 This study will assess whether switching participants who have benefitted f...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 To evaluate the effect of the drug in moderate to severe Chronic Obstructiv...
Show More Learn More & Join Trial